On June 15th, the "2025 Frontier Research Summit on Microenergy Medicine Mechanisms and Clinical Applications," co-hosted by the Chinese Society of Sexual Medicine and Peking University First Hospital, successfully concluded. The summit gathered leading global experts in the field of microenergy medicine, engaging in in-depth discussions on basic research, technological breakthroughs, and clinical translation. This event injected strong momentum into medical innovation driven by interdisciplinary integration.

As a leading company in China's microenergy medicine field, Beijing WBL Medical Equipment Co., Ltd. (hereinafter referred to as "WBL Medical Group") was invited to attend. During the forum, Chairman Mr. Guo Mao of WBL Medical Group gathered with top domestic and international experts. During the event, Chairman Guo, along with Mr. Jiang Hui, Party Secretary of Peking University First Hospital, and Professor Lü Futai from the University of California, unveiled the "Microenergy Medicine Research Center" at the Peking University Urology Institute, marking a key step in the industrialization of China's microenergy medicine sector.

At the same time, Peking University First Hospital, the Chinese Society of Sexual Medicine, the University of California, San Francisco, and WBL LIPUS Clinical Research and Application Cooperation Center jointly established the "Energy Medicine Research Center," aiming to drive the innovative development and practical application of microenergy medicine.

Additionally, the "LIPUS Clinical Research and Application Cooperation Center" was officially announced at the forum. The center, led by experts such as Lü Futai, Jiang Hui, and Xia Shujie, focuses on the standardization of LIPUS technology research and the promotion of its industrialization.

The core focus of the meeting was the groundbreaking progress of Low-Intensity Pulsed Ultrasound (LIPUS) technology. Studies showed that WBL LIPUS demonstrated significant efficacy in treating male erectile dysfunction, boosting testosterone levels, and anti-aging, with its combination with moxibustion and aromatherapy offering a new non-invasive treatment approach. Animal experiment data further validated LIPUS's potential in urethral repair, with experts at the event hailing it as a "milestone in the post-Viagra era of male health physical repair."

During the academic exchange session, American experts, including Professor Lü Futai and Professor Lin Guiting, shared cutting-edge international research results. Domestic leaders, including Secretary Jiang Hui and President Dai Yutian, proposed innovative directions based on China's clinical needs, forming a complete logical chain from international perspectives to local practices, laying an important foundation for the localization development of microenergy medicine.

Jiang Hui: Party Secretary of Peking University First Hospital, Director of Peking University Urology Department, President of the Chinese Society of Sexual Medicine

Lü Futai: Professor and Associate Director of Urology at the University of California, San Francisco

Lin Guiting: Professor of Urology at the University of California, San Francisco, Associate Director of the Urology Molecular Research Institute

Xia Shujie: Vice President of Shanghai First People's Hospital

Xu Zhipeng: Director of Urology at Ningbo Yinzhou Second Hospital

Liang Lili: Chief Physician, Urology Department, Peking University First Hospital

After the meeting, Secretary Jiang Hui, Professor Lü Futai, and Professor Lin Guiting visited Peking University’s laboratories and Urology Center to gain deeper insights into the clinical application scenarios of LIPUS technology and the research transformation pathway, laying the foundation for future collaboration between industry, academia, and research.

The successful hosting of this summit marks a new stage in the deep integration of production, education, research, and application in China's microenergy medicine research. The breakthrough of WBL LIPUS technology not only provides a new non-invasive repair option for male health but will also propel microenergy medicine to become a vital branch of clinical treatment. With the deepening of international cooperation and technological iteration, WBL LIPUS is expected to reshape the management landscape of chronic diseases, providing safer and more efficient solutions for patients worldwide and opening a new chapter in physical regenerative medicine.